West Pharmaceutical Services, Inc. (WST) is expected to report earnings on Thursday, October 22, 2026, before the open. Estimated release time 07:19 ET. Consensus EPS estimate is $2.18.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | FY2026 Q2 | $2.08 | $2.37 | +13.9% | $872.30M |
| 2026-04-23 | FY2026 Q1 | $1.68 | $2.13 | +26.8% | $844.90M |
| 2026-02-12 | FY2025 Q4 | $1.83 | $2.04 | +11.5% | $805.00M |
| 2025-10-23 | FY2025 Q3 | $1.68 | $1.96 | +16.7% | $804.30M |
| 2025-07-24 | FY2025 Q2 | $1.51 | $1.84 | +21.9% | $766.20M |
| 2025-04-24 | FY2025 Q1 | $1.22 | $1.45 | +18.9% | $698.00M |
| 2025-02-13 | FY2024 Q4 | $1.71 | $1.82 | +6.4% | $748.80M |
| 2024-10-24 | FY2024 Q3 | $1.50 | $1.85 | +23.3% | $746.90M |
WST has beaten consensus EPS in 8 of its last 8 reported quarters.
See WST on the live calendar →